Arixtra en es it fr

Arixtra Brand names, Arixtra Analogs

Arixtra Brand Names Mixture

  • No information avaliable

Arixtra Chemical_Formula

C31H43N3Na10O49S8

Arixtra RX_link

http://www.rxlist.com/cgi/generic3/arixtra.htm

Arixtra fda sheet

Arixtra FDA

Arixtra msds (material safety sheet)

Arixtra MSDS

Arixtra Synthesis Reference

No information avaliable

Arixtra Molecular Weight

1726.77 g/mol

Arixtra Melting Point

No information avaliable

Arixtra H2O Solubility

No information avaliable

Arixtra State

Liquid

Arixtra LogP

No information avaliable

Arixtra Dosage Forms

Solution

Arixtra Indication

For the treatment of prophylaxis of deep vein thrombosis.

Arixtra Pharmacology

Fondaparinux is a synthetic and specific inhibitor of activated Factor X (Xa) indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism. Fondaparinux is also indicated for the treatment of acute deep vein thrombosis when administered in conjunction with warfarin, and the treatment of acute pulmonary embolism when administered in conjunction with warfarin. Fondaparinux does not inactivate thrombin (activated Factor II) and has no known effect on platelet function. At the recommended dose, Fondaparinux does not affect fibrinolytic activity or bleeding time.

Arixtra Absorption

100%

Arixtra side effects and Toxicity

No information avaliable

Arixtra Patient Information

No information avaliable

Arixtra Organisms Affected

Humans and other mammals